FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pfizer HYDROmorphone HCl Injection Recall

HYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of…

Pfizer Inc. · New York, NY

Risk level
Class II
Reported by FDA
Sep 27, 2017
Recall ID
D-1167-2017
Check your lot numberHow we source this data

Summary

Pfizer recalled HYDROmorphone HCl Injection starting Aug 22, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1167-2017 on Sep 27, 2017. Reason: Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process. Status: Terminated.

Why it was recalled

Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.

Product description

HYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3365-11 (carton) and 0409-3365-01(vial)

Lot numbers, UPCs & expiration codes

Lot: 760853A

Where it was sold

United States Nationwide (including Puerto Rico) and Singapore

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1167-2017
Classification
Class II
Status
Terminated
Recall initiated
Aug 22, 2017
FDA report date
Sep 27, 2017
Quantity
115,370 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-1167-2017, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
77956
Address
235 E 42nd St
Code information
Lot: 760853A
Postal code
10017-5703
Report date
Sep 27, 2017
Product type
Drugs
Recall number
D-1167-2017
Classification
Class II
Recalling firm
Pfizer Inc.
Product quantity
115,370 vials
Termination date
Feb 19, 2023
Reason for recall
Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.
Voluntary / mandated
Voluntary: Firm initiated
Product description
HYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3365-11 (carton) and 0409-3365-01(vial)
Distribution pattern
United States Nationwide (including Puerto Rico) and Singapore
Recall initiation date
Aug 22, 2017
Initial firm notification
Letter
Center classification date
Sep 15, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1167-2017, published Sep 27, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls